Evidence map›Paper›PMID 40280124›Full record

ArticleCancer cell2025

Stromal lipid species dictate melanoma metastasis and tropism.

Shilpa Gurung, Timothy Budden, Karthik Mallela, Benjamin Jenkins, Alex von Kriegsheim, Esperanza Manrique, David Millán-Esteban, Isabel Romero-Camarero, Fabio Amaral, Sarah Craig and 17 more

Abstract read
In one paragraph

Article in Cancer cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. DHX37 and tumor growth: a novel avenue for melanoma research.Journal of translational medicine · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Decoding the Role of Lipid Metabolism and Membrane Dynamics in Melanoma.International journal of molecular sciences · 2026
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Ageing, immune fitness and cancer.Nature reviews. Cancer · 2025
    Review
  20. Emerging Roles of Ferroptosis in Skin Pathophysiology.The Journal of investigative dermatology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Shilpa GurungSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK.
Timothy BuddenSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK.
Karthik MallelaSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK.
Benjamin JenkinsWellcome Trust - MRC Institute of Metabolic Science Metabolic Research Laboratories, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK; Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, University of Cambridge, Fulbourn Road, Cambridge CB1 9NL, UK.
Alex von KriegsheimCRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh EH4 2XU, UK.
Esperanza ManriqueSchool of Medicine, Universidad Católica de Valencia, San Vicente Mártir, 46001 Valencia, Spain; Department of Dermatology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
David Millán-EstebanSchool of Medicine, Universidad Católica de Valencia, San Vicente Mártir, 46001 Valencia, Spain; Department of Dermatology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Isabel Romero-CamareroLeukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK.
Fabio AmaralLeukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK.
Sarah CraigSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK.
Pedro DuraoSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK.
Joanna PozniakLaboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium.
Laura StennettImaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, Guy's Campus, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, UK.
Duncan SmithProteomics, Cancer Research UK Manchester Institute, The University of Manchester, Manchester SK10 4TG, UK.
Garry AshtonHistology, Cancer Research UK Manchester Institute, The University of Manchester, Manchester SK10 4TG, UK.
Alex BakerVisualisation, Irradiation & Analysis, Cancer Research UK Manchester Institute, The University of Manchester, Manchester SK10 4TG, UK.
Kang ZengVisualisation, Irradiation & Analysis, Cancer Research UK Manchester Institute, The University of Manchester, Manchester SK10 4TG, UK.
Gilbert FruhwirthImaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Studies, King's College London, Guy's Campus, London, UK; School of Biomedical Engineering and Imaging Sciences, King's College London, St. Thomas' Hospital, London, UK.
Victoria Sanz-MorenoCytoskeleton and Metastasis Team, The Breast Cancer Now Toby Robins Research Centre Division of Breast Cancer Research, The Institute of Cancer Research, Chester Beatty Laboratories, London SW3 6JB, UK; Centre for Tumour Microenvironment at Barts Cancer Institute, Queen Mary University of London, Charterhouse Square Campus, John Vane Science Centre, London, UK.
Jair MarquesCRUK Scotland Centre, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh EH4 2XU, UK.
Albert KoulmanWellcome Trust - MRC Institute of Metabolic Science Metabolic Research Laboratories, Addenbrooke's Hospital, Hills Road, Cambridge CB2 0QQ, UK; Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, University of Cambridge, Fulbourn Road, Cambridge CB1 9NL, UK.
Jean-Christophe MarineLaboratory for Molecular Cancer Biology, Center for Cancer Biology, VIB, Leuven, Belgium; Department of Oncology, KU Leuven, Leuven, Belgium.
Tim C P SomervailleLeukaemia Biology Laboratory, Cancer Research UK Manchester Institute, The University of Manchester, Manchester M20 4GJ, UK.
Luisa MottaDepartment of Histopathology, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester, UK.
Caroline Gaudy-MarquesteAix Marseille University, APHM, CRCM Inserm U1068, CNRS U7258, CHU Timone, Dermatology and Skin Cancer Department, Marseille, France.
Eduardo NagoreSchool of Medicine, Universidad Católica de Valencia, San Vicente Mártir, 46001 Valencia, Spain; Department of Dermatology, Fundación Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Amaya VirósSkin Cancer and Ageing Lab, Cancer Research UK Manchester Institute, the University of Manchester, Manchester, UK; NIHR Manchester Biomedical Research Centre, Manchester, UK; Department of Dermatology, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester, UK. Electronic address: amaya.viros@cruk.manchester.ac.uk.

Funding

Cancer Research UK A27412Department of Health NIHR203308Wellcome Trust 110078
6 · The paper itself

Abstract

Cancer cells adapt to signals in the tumor microenvironment (TME), but the TME cues that impact metastasis and tropism are still incompletely understood. We show that abundant stromal lipids from young subcutaneous adipocytes, including phosphatidylcholines, are taken up by melanoma cells, where they upregulate melanoma PI3K-AKT signaling, fatty acid oxidation, oxidative phosphorylation (OXPHOS) leading to oxidative stress, resulting in decreased metastatic burden. High OXPHOS melanoma cells predominantly seed the lung and brain; decreasing oxidative stress with antioxidants shifts tropism from the lung to the liver. By contrast, the aged TME provides fewer total lipids but is rich in ceramides, leading to lower OXPHOS and high metastatic burden. Aged TME ceramides taken up by melanoma cells activate the S1P-STAT3-IL-6 signaling axis and promote liver tropism. Inhibiting OXPHOS in the young TME or blocking the IL-6 receptor in the aged TME reduces the age-specific patterns of metastasis imposed by lipid availability.

Indexed as

Lipid MetabolismMelanomaAnimalsCell Line, TumorHumansLiver NeoplasmsLung NeoplasmsMiceMice, Inbred C57BLNeoplasm MetastasisOxidative PhosphorylationOxidative StressSignal TransductionStromal CellsTumor Microenvironmentaged skinaginglipid metabolismliver tropismmelanomamelanoma metastasismetastasisoxidative stressOXPHOStropism

Identifiers

PMID40280124
PMCPMC7618647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.